...mos in favor of upfront vs delayed ZA group. ZA was safe and well tolerated. Updated 12 mos BMD data on all pts will be ...
...mos, 6 mos, and 9mos). It was assumed that the injection site remained in the breast until complete decay of the technet...
...mos, respectively. At wk 8, 10 pts had some degree of cytoreduction; however, most was short-lived. One pt remains on st...
...mos (95% CI 3.5-9.4). Median OS has not been reached yet (14+ mos). 14 pts have died of PD. 61 pts had interruption of t...
...mos. vs. 10 mos., p<.001).,Survivals of highly selected patients with metastatic renal cancer are similar whether they r...
...mos [lung] to 15 mos [breast]). After matching for age, gender, and comorbidities using propensity score, there were 201...
...mos post-op, 78% of patients rated their QL as stable or improved (95% CI: 64% - 92%). A subgroup (7 of 33 pts) reported...
...mos (95% CI 7.6-12.2) vs M-VAC 8.1 mos (95% CI 7.0-9.9). (p=.017; HR=0.73; 95% CI 0.56 - 0.95). The median survival was ...
...mosome 5q31 is the most common CTG abnormality in MDS characterized by TD-anemia and megakaryocyte dysplasia. In a phase...
5168 Background: For most patients (pts), peritoneal carcinomatosis has an ominous prognosis and chemotherapy gives some...
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话: 0531-88819269